Custom Search

News

Tuesday 01 November 2005

[Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial]

By: Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC; The Cosmic COPD and Serentide: A Multi-Center Intervention and Characterization Study Group.

Rev Port Pneumol 2005 Nov-Dec;11(6):587-9

No abstract available

Use of this site is subject to the following terms of use